SUBSCRIBE
SUBSCRIBE

ReCode Therapeutics

NEWS
Business
Belldegrun’s Third Fund Continues “Bold Investment Strategy” with $825 Million
Vida Ventures III will approach investments the same way its first two funds do, identifying and investing in what they believe to be transformative biomedical innovative companies.
June 24, 2021
 · 
3 min read
 · 
Mark Terry
Drug Development
Inside ReCode’s New-in-Class Approach to Treating Cystic Fibrosis
The data showed that both experimental therapies restored function in the cystic fibrosis transmembrane conductance regulator gene.
June 17, 2021
 · 
5 min read
 · 
Heather McKenzie
Load More
JOBS
IN THE PRESS
Press Releases
ReCode Therapeutics Initiates Enrollment of Phase 2 Clinical Trial of RCT2100 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis
November 18, 2025
 · 
3 min read
Press Releases
ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update
September 30, 2025
 · 
3 min read
Press Releases
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT2100 for the Treatment of Cystic Fibrosis
March 26, 2025
 · 
3 min read
Press Releases
CF Foundation Invests Up to $15 million in ReCode Therapeutics to Develop a Gene Editing Therapy
November 19, 2024
 · 
2 min read
Press Releases
ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
November 18, 2024
 · 
4 min read
Press Releases
ReCode Announces Two Key Additions to Scientific Advisory Board
October 1, 2024
 · 
5 min read
Press Releases
ReCode Therapeutics Presents Preclinical Data from its Cystic Fibrosis Program at the 2024 North American Cystic Fibrosis Conference (NACFC) in Boston
September 27, 2024
 · 
4 min read
Press Releases
ReCode Therapeutics Doses First Patient in Phase 1b Clinical Study of RCT2100 for the Treatment of Cystic Fibrosis
September 27, 2024
 · 
3 min read
Business
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
May 13, 2024
 · 
3 min read
Biotech Bay
ReCode Therapeutics to Participate in May Conferences
May 1, 2024
 · 
2 min read
Load More